Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. (APLS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APLS · as of Jun 8, 2026
Key Statistics
Explore Apellis Pharmaceuticals, Inc. Data
apls stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 25 · Buy rate: 72.0%
The APLS analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $33.40, representing -18.60% downside from the current price of $41.03.
Competitors & Peers
apls competitorsAPLS
ADPT
AGIO
BEAM
CDTX
CPRXStock Performance
Full HistoryAbout Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. is an actively operating biopharmaceutical enterprise dedicated to the discovery, advancement, and commercialization of therapeutic agents. Its core strategy involves mod…
what is apellis pharmaceuticals, inc. · apls stock overview · apellis pharmaceuticals, inc. company profile · who is apellis pharmaceuticals, inc. ceo · apls NASDAQ · apellis pharmaceuticals, inc. headquarters · apellis pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Apellis Pharmaceuticals, Inc. (APLS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 9, 2017. As of the latest trading session, APLS stock price is $41.03, with a market capitalization of $5.3B. The stock has returned +111.60% over the past 12 months and +63.34% year-to-date.
According to 25 Wall Street analysts, the consensus rating for Apellis Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $33.40. In fiscal year 2025, Apellis Pharmaceuticals, Inc. reported revenue of $1.0B and net income of $22.4M. For detailed data — including Apellis Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Apellis Pharmaceuticals, Inc. (APLS) stock price is $41.03. The stock is traded on NASDAQ under the ticker symbol APLS. The 52-week range is $16.61 – $41.14.